Medical expert analysis emphasizes that the combination of meniscal damage and cartilage injury could raise short- and long-term concerns, potentially explaining why Crosby did not pass a pre-trade physical. This development would also complicate any future trade discussions for Crosby, as teams weigh premium draft picks and large salaries against the risk of a renewed knee issue.
Crosby’s offseason has included a blockbuster swap to the Ravens that never materialized due to the medical concerns, after which he publicly indicated he would be with the Raiders for the 2026-27 season. Despite that statement, the medical findings have kept the door open for ongoing trade conversations, as teams monitor Crosby’s health trajectory and potential rebuilding of offers as the draft approaches.
NFL observers note that even if Crosby remains with Las Vegas, the situation remains fluid. A prominent football insider suggested that while Crosby is currently a Raider, talks of a trade could resume later in the offseason or closer to the season if the right offer emerges, keeping options open for teams such as the Cowboys or other contenders.
The evolving medical assessment raises questions for both the Lions and the Raiders about Crosby’s reliability and value. For Detroit, the pursuit may have to pivot to other pass-rush targets, while Las Vegas must weigh the balance between Crosby’s current status and future trade viability given the potential long-term cartilage damage.
In summary, Crosby’s health status is central to the ongoing trade discussions surrounding him. While he remains with the Raiders for now, medical findings underscored by a documented knee injury could keep the door open for future dealings, dependent on evolving evaluations and the NFL landscape ahead of the draft.
